NVOX logo

NVOXDefiance Daily Target 2X Long NVO ETF

$13.13
$0.53
(3.88%)
Today
Closed $13.13
$0.12
(0.91%)
After Hours
Updated: 07:57 PM EDT
Vol444,254.00
52W High$72.16
52W Low$9.23
News
all
press releases
News Placeholder
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
<
...
1
>

Advertisement|Remove ads.